| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 03/02/2011 | EP2289896A1 Process for the manufacture of 3-dibutylamino-6-methyl-7-anilinofluoran |
| 03/02/2011 | EP2289895A1 Anthanthrene based compound and semiconductor device |
| 03/02/2011 | EP1853592B1 Synthesis of himbacine analogs |
| 03/02/2011 | CN101983202A Luminescence quenchers and fluorogenic probes for detection of reactive species |
| 03/02/2011 | CN101982465A Flavonoid compound extracted from liquorice and preparation method and application thereof |
| 03/02/2011 | CN101538272B Phenyl propanoid derivative, preparation method thereof and application thereof to preparation of medicines resisting breast cancer |
| 03/01/2011 | USRE42191 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 03/01/2011 | US7897793 Process for preparation of 13,14-dihydro-PGF2 alpha derivatives |
| 03/01/2011 | US7897791 Purifications of pomegranate ellagitannins and their uses thereof |
| 03/01/2011 | US7897635 HIV protease inhibitors |
| 02/24/2011 | WO2011020726A1 Process for the manufacture of 3-dibutylamino-6-methyl-7-anilinofluoran |
| 02/24/2011 | US20110046182 Efficient aspirin prodrugs |
| 02/24/2011 | US20110043746 Benzo[f]chrome any pyrano[3,2-f]chrome derivatives for use in liquid crystal media |
| 02/24/2011 | US20110042658 Anthanthrene based compound and semiconductor device |
| 02/24/2011 | US20110042652 Electroactive materials |
| 02/24/2011 | US20110042614 Chiral compounds, liquid crystal compositions and polymer networks derived therefrom |
| 02/23/2011 | EP2287168A2 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2285794A2 Chromane derivatives as trpv3 modulators |
| 02/22/2011 | US7893265 Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same |
| 02/22/2011 | CA2411818C Cyclopentabenzofuran compounds and uses thereof |
| 02/22/2011 | CA2329181C 12,13-modified epothilone derivatives |
| 02/22/2011 | CA2263409C High molecular weight polymer-based prodrugs |
| 02/17/2011 | WO2011017998A1 Gambogic acid cyclization analogues, preparation method and application thereof |
| 02/17/2011 | US20110038952 Gambogic acid glycoside derivatives and analogs, their preparation methods and applications |
| 02/16/2011 | EP2283159A1 Synthesis of (+) cortistatin a and related compounds |
| 02/16/2011 | EP2283023A2 Bryostatin analogues and methods of making and using thereof |
| 02/16/2011 | CN101974043A Method for preparing punicalagin and ellagic acid from pomegranate rind |
| 02/16/2011 | CN101974014A Manufacturing technology for extracting ginkalide A and C from root and bark of maidenhair tree |
| 02/16/2011 | CN101974013A Compounding method of Maoecrystal |
| 02/16/2011 | CN101974012A Novel compound ethyl brevicate with pharmaceutical activity |
| 02/16/2011 | CN101974011A New compound methyl brevicate with medical activity |
| 02/16/2011 | CN101974010A New compound erigeron breviscapus acid with officinal activity |
| 02/16/2011 | CN101974009A Process for separating imperatorin from osthole extract waste liquid |
| 02/16/2011 | CN101974008A Process for extracting and purifying podophyllotoxin from Dysosma difformis |
| 02/16/2011 | CN101974007A Method for extracting bergenin from traditional Chinese medicine rodgersia podophylla |
| 02/16/2011 | CN101974006A Method for extracting podophyllotoxin from umbrella leaf |
| 02/16/2011 | CN101972246A Medicament for treating cancer, preparation method thereof and application thereof to preparation of medicaments |
| 02/16/2011 | CN101531666B Process for extracting limonin from shaddock kernel |
| 02/16/2011 | CN101434606B Polypropylene transparent nucleating agent production method |
| 02/15/2011 | US7888388 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 02/15/2011 | US7888367 reverse transcriptase mutants which allow an obligate chain terminating nucleoside- or nucleotide phosphate to be excised from the nascent DNA strand by ATP- or pyrophosphate-mediated excision |
| 02/15/2011 | US7888285 2,4,6-phenyl substituted cyclic ketoenols |
| 02/15/2011 | CA2444895C Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/10/2011 | WO2011016351A1 Dna synthase inhibitors |
| 02/10/2011 | US20110034688 Optically active dibenzazepine derivatives |
| 02/10/2011 | US20110034486 Use of pterocarpans as active anti-cellulite ingredients |
| 02/10/2011 | US20110034404 Pest control agents |
| 02/10/2011 | US20110033457 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 02/10/2011 | US20110031488 Compound for organic thin-film transistor and organic thin-film transistor using the compound |
| 02/09/2011 | EP2280981A1 Bridged heterocycles as hiv integrase inhibitors |
| 02/09/2011 | EP2280979A2 Production of 5-membered and 6-membered cyclic esters of polyols |
| 02/09/2011 | CN101970445A Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors |
| 02/09/2011 | CN101967153A Metabolite of 10-O-(dimethylamino ethyl) ginkgolides B and medicinal composition containing same |
| 02/09/2011 | CN101967152A New methylenedioxy xanthone compound and anti-tumor effect thereof |
| 02/09/2011 | CN101967151A Preparation method for natural product podophyllotoxin |
| 02/09/2011 | CN101619067B Large ring lactone compound and preparation method thereof |
| 02/09/2011 | CN101463037B Method for synthesizing taspine |
| 02/09/2011 | CN101289453B Ellagic acid compounds preparation method |
| 02/08/2011 | US7883714 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/08/2011 | CA2622694C Substituted cycloalkene derivative |
| 02/03/2011 | WO2011012622A1 Benzoxazinone derivatives for the treatment of glytl mediated disorders |
| 02/03/2011 | WO2010091193A3 Triptolide c-ring derivatives as anticancer agents and immune modulators |
| 02/03/2011 | US20110028540 Synthesis of macrocyclic cancer chemotherapy agents and methods of use |
| 02/03/2011 | US20110028539 Biologically active taxane analogs and methods of treatment |
| 02/03/2011 | US20110028382 Treatment of oral pharyngeal dysphagia |
| 02/02/2011 | EP2280014A2 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 02/02/2011 | EP2280003A2 Process for preparing receptor-type kinase modulators |
| 02/02/2011 | EP2089371B1 Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol |
| 02/02/2011 | EP1485358B1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
| 02/02/2011 | CN1980655B Lipase inhibitor |
| 02/02/2011 | CN1942473B Process for producing pentacyclic taxane |
| 02/02/2011 | CN101965352A Pyripyropene derivative having acat2-inhibiting activity |
| 02/02/2011 | CN101965343A 2-aza-bicyclo[2.2.1]heptane derivatives |
| 02/02/2011 | CN101962386A Process for extracting arteannuin by biological compound enzymes |
| 02/02/2011 | CN101962385A Method for preparing bergeninum |
| 02/02/2011 | CN101580509B Method for producing electronic-grade pyromellitic dianhydride from secondary trapped coarse anhydride |
| 02/02/2011 | CN101475576B Flavone lignose compound, and preparation and pharmaceutical use thereof |
| 02/01/2011 | US7879904 9, 10-α,α-OH-taxane analogs and methods for production thereof |
| 02/01/2011 | US7879492 redox system; lithium batteries; nontoxic; improved electroconductivity |
| 01/27/2011 | WO2011011783A1 Spectinamides as anti-tuberculosis agents |
| 01/27/2011 | WO2011011721A2 Compounds, compositions and methods for protecting brain health in neurodegenerative disorders |
| 01/27/2011 | WO2011011303A1 Inhibitors of flaviviridae viruses |
| 01/27/2011 | WO2011009203A1 Methods of making efavirenz and intermediates thereof |
| 01/27/2011 | US20110021625 Neuronal cell death inhibitor |
| 01/27/2011 | US20110021549 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 01/27/2011 | CA2768963A1 Compounds, compositions and methods for protecting brain health in neurodegenerative disorders |
| 01/27/2011 | CA2768712A1 Methods of making efavirenz and intermediates thereof |
| 01/27/2011 | CA2767088A1 Inhibitors of flaviviridae viruses |
| 01/26/2011 | EP2277898A2 Rapamycin analogues |
| 01/26/2011 | EP2277880A1 Macrolides with VEGF transcription suppression activity |
| 01/26/2011 | EP2277873A1 Intermediate compound for the preparation of halichondrin analogs |
| 01/26/2011 | EP2277872A1 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions |
| 01/26/2011 | EP2277867A2 Compounds, pharmaceutical compositions thereof and their use in treating cancer |
| 01/26/2011 | EP2203439B1 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones |
| 01/26/2011 | EP1861402B1 Isoflavonoid dimers |
| 01/26/2011 | CN1927861B Garcinia acid derivatives, preparation method and application thereof in pharmacy |
| 01/26/2011 | CN1796388B Sesamin/episesamin compositions |
| 01/26/2011 | CN101955490A Method purifying angelica dahuricae |
| 01/26/2011 | CN101955489A Method for extracting phellopterin from changium smyrnioide root bark |